Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Asset Writedowns and Impairment (2015 - 2016)

Chemours' quarterly Asset Writedowns and Impairment came in at $46.0 million in Q3 2016, up 2.22% year-on-year from $45.0 million in Q4 2015, and down 20.69% quarter-over-quarter from $58.0 million in Q2 2016.

Chemours has reported Asset Writedowns and Impairment for 2 years, with the latest figure at $46.0 million in Q3 2016.

  • For the quarter ending Q3 2016, Asset Writedowns and Impairment rose 2.22% year-over-year to $46.0 million; the trailing twelve-month figure through Sep 2016 stood at $152.0 million (up 237.78% YoY), and the FY2015 full-year result was $48.0 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment for Q3 2016 stood at $46.0 million, down from $58.0 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $58.0 million in Q2 2016, with the low at $3.0 million in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn
10 Chemours 3.38 Bn 3.38 Bn 212.00 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2016 46.00 Mn
Sep 30, 2016 46.00 Mn
Jun 30, 2016 58.00 Mn
Jun 30, 2016 58.00 Mn
Dec 31, 2015 3.00 Mn
Dec 31, 2015 3.00 Mn
Sep 30, 2015 45.00 Mn
Sep 30, 2015 45.00 Mn